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T H E DIAGNOSIS OF VENOGENIC IMPOTENCE: DYNAMIC OR 
PHARMACOLOGIC CAVERNOSOMETRY? 
C H R I S T I A N G. S T I E F , W O L F G A N G D I E D E R I C H S , F R A N C O I S B E N A R D , R U U D B O S C H , 
T O M F . L U E * A N D E M I L A. T A N A G H O 
From the Department of Urology, University of California, San Francisco, California and the Department of Urology, University Clinics, 
Freiburg, FRG 
ABSTRACT 
In an attempt to refine the diagnosis of venogenic impotence, we evaluated different techniques 
of cavernosometry in 10 dogs. Saline was perfused intracavernously in five dogs to induce erection. 
Regardless of the amount required for induction, a mean flow rate of 23.4 ml./min. was necessary 
to maintain an intracavernous pressure level of 110 cm. H 2 0 . In seven dogs, a leak was created by 
intracavernous insertion of a 19-gauge needle. When erection was induced by either cavernous nerve 
stimulation or a combination of papaverine injection and saline perfusion, the mean flow through 
the needle was significantly less than when erection was induced by saline perfusion alone (1.73, 
1.78, and 8.77 ml./min., respectively). Sympathetic trunk stimulation at the level of L5 could reduce 
the intracavernous pressure by 90% in erections induced by neural stimulation or papaverine plus 
perfusion but had no effect on erection induced by saline perfusion alone. Our findings show that 
cavernosometry after intracavernous injection of papaverine will provide more valuable information 
in patients in whom venogenic impotence is suspected. (J. Urol, 140: 1561-1563, 1988) 
During erection, penile rigidity can be prevented by excessive 
cavernous vein outflow, to which numerous factors may con­
tribute: pathological changes of the cavernous smooth muscles;1 
abnormal local venous drainage;2 insufficient neurotransmitter 
release; and alteration of the cavernous endothelium.3 
In 1978, Virag et al. introduced dynamic cavernosography.4 
Saline was infused at increasing rates of flow until the intra­
cavernous pressure plateaued at the full erection stage, 80 mm. 
Hg (at which point it was assumed that saline perfusion had 
effected closure of the venous channels). The lowest rate needed 
to induce erection was called the induction flow. The lowest 
rate needed to maintain erection was named the maintenance 
flow. The ratio of induction flow to maintenance flow, the 
maintenance index, was suggested as a diagnostic parameter 
for venogenic impotence. The penis was then perfused with 
contrast medium to opacify the abnormally draining veins. In 
1986, Lue et al. 5 suggested that cavernosometry be done after 
intracavernous injection of papaverine (pharmacocavernoso-
metry) because the resultant erection more closely mimics the 
normal physiologic event. 
We undertook this study to determine which method of 
cavernosometry would provide the most useful diagnostic in­
formation. The dog was chosen as the experimental model 
because canine erection lacks the tumescent phase and the 
pressure increase from flaccidity to rigidity can be readily 
quantified. 
MATERIALS AND METHODS 
Ten dogs, weighing 32 to 41 kg., were used. In dogs 1 to 5, 
two 21-gauge needles were inserted into the right corpus cav-
[ ernosum. One was connected to a Harvard perfusion pump 
(Mod. 903), the other to a Statham transducer (mod. Ρ 23 AC) 
for pressure recording (Grass mod. 7 polygraph) (fig. 1). An 
artificial erection with an intracavernous pressure of 110 cm. 
H 2 0 was induced by intracavernous perfusion of saline. Three 
different perfusion modes were used (fig. 2). First, the rate was 
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gradually increased by 3.82-ml./min. increments after the pres­
sure had plateaued. The maximal rate was 45.8 ml./min. We 
then used the same incremental rise but stopped the perfusion 
and waited for the intracavernous pressure to return to baseline 
before increasing the flow rate. Thirdly, we perfused saline at 
an initially high rate of 26.7 ml./min. All measurements were 
repeated twice to verify reproducibility. 
In dogs 4 to 10, a 19-gauge needle was inserted into the right 
corpus cavernosum to create an artificial leak. Two 21-gauge 
needles were inserted and connected as above. After a full 
erection was obtained by electrical stimulation of the cavernous 
nerve6 or saline perfusion, the flow through the needle and the 
drop in intracavernous pressure were recorded. Erection was 
again induced, this time by intracavernous injection of two mg. 
papaverine and saline perfusion, and the cavernous leakage and 
intracavernous pressure drop were again measured. 
In dogs 4 to 10, cuff electrodes were also placed around the 
sympathetic trunk at the level of L5. 7 After inducing a full 
erection by cavernous nerve stimulation, saline perfusion, or 
papaverine injection plus saline perfusion, electrical stimula­
tion was applied (20 Hz, 3V). Sympathetic stimulation was also 
applied 30 seconds before and then during saline perfusion to 
determine whether it can influence the intracavernous pressure 
change induced by saline perfusion alone. 
FlG. 1. Canine corpus cavernosum with placement of needles for 
cavernosometry. 
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mean rate of flow through the leak was 1.78 ml./min., much 
lower than with saline perfusion alone (table 1). 
Electrical stimulation of the sympathetic trunk reduced the 
intracavernous pressure by 90% in erections induced by either 
cavernous nerve stimulation or by two mg. papaverine plus 
saline perfusion (fig. 3A, B). Sympathetic trunk stimulation 
did not influence the intracavernous pressure of an erection 
induced by saline perfusion alone. It could neither abolish nor 
significantly reduce the erection induced by saline perfusion 
when sympathetic stimulation was applied 30 seconds before 







(cm H 2 0 ) 
T7~ 
26 74 30 56 34.38 
Perfusion (ml/mm) 
F I G . 2. Intracavernous pressures induced by A, perfusion rates in­
creased by 3.82-ml./min. increments after pressure had plateaued; B, 
perfusion rates increased by same increment after pressure had re­
turned to baseline; and C, initially high perfusion rate (26.74 ml./min.) 
followed by same incremental increases as in A and B. 
R E S U L T S 
The intracavernous pressure levels induced by saline perfu­
sion were identical at a given perfusion rate, regardless of 
whether we continuously increased the flow rate or waited for 
the pressure to return to baseline before so doing (fig. 2). The 
pressure rose off the scale (>200 cm. H 2 0) only when the initial 
perfusion rate was 34.4 ml./min. or higher (fig. 2C). However, 
when the perfusion rate was increased gradually (fig. 2A and 
JB), it was possible to perfuse at a rate higher than 34.4 ml./ 
min. without provoking a pressure level >200 cm. H 2 0. These 
findings were reproducible twice in the same animals. 
Creation of the artificial leakage resulted in a mean pressure 
drop of 65 cm. H 2 0, regardless of mode of induction. When 
erection was induced by cavernous nerve stimulation, the mean 
rate of flow through the leak was 1.73 ml./min.; with erection 
induced by saline perfusion alone, the mean rate was 8.77 ml./ 
min. Within 60 seconds after intracavernous injection of two 
mg. papaverine, cavernous smooth muscle relaxation was ob­
tained with a mean intracavernous pressure of 40 cm. H 2 0. 
Only one dog (#8) did not respond to papaverine. In the six 
that did respond to papaverine, a mean saline perfusion rate of 
4.3 ml./min. was necessary to maintain full erection, and the 
TABLE 1. Rate of drainage through the artificial cavernous leak in 
canine erection induced by various means 





4 22.0* 2.4 2.9 
5 5.8 1.3 0.6 
6 12.0 1.8 1.4 
7 3.3 0.9 0.9 
8 3.5 0.9 No reaction to 
papaverine 
9 7.0 2.8 2.5 
10 7.8 2.0 2.4 
* All values are ml./min. 
-Cavernous Stim. 
Β 
2 mg Papaverine 





F I G . 3. Effect of sympathetic trunk stimulation (L5) on intracav­
ernous pressure increases induced by A, electrical stimulation of the 
cavernous nerve; B, two mg. papaverine plus saline perfusion; and C 
saline perfusion alone. 
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DISCUSSION 
The mode of saline perfusion, whether by continuous incre­
mental increases or by interrupted increases with a return to 
baseline between increments, did not influence the level of 
intracavernous pressure provoked by a given perfusion rate. 
Only in response to an initially high perfusion rate did the 
pressure rise acutely, presumably by surpassing the compliance 
of the cavernous tissue and the venous system. By gradually 
increasing the flow rate, the venous channels may remain open 
and perfusion rates far in excess of 34.4 ml./min. can be 
accommodated. 
Because the penile venous drainage capacity during erection 
is determined quantitatively by the maintenance flow, tumes­
cence will result if a rate higher than the maintenance flow 
rate is used to induce an erection. Thus, the flow rate required 
to induce an erection depends on the size of the penis and the 
maintenance flow rate. The induction flow therefore has no 
diagnostic usefulness in the evaluation of venous leakage. 
The amount of flow through the artificial leak was similar in 
erection induced by neurostimulation or by papaverine and 
saline (1.73 and 1.78 ml./min., respectively). However, in erec­
tion induced by saline perfusion alone, the flow was five times 
higher (8.77 ml./min.). This can be explained by the fact that 
the smooth muscles remain contracted in saline-induced erec­
tion and permit a free flow from the perfusion needle to the 
leak. In contrast, the relaxation of the cavernous smooth mus­
cles with neurostimulation or papaverine injection results in 
outflow resistance and does not permit this high rate of trans-
cavernous flow. 
Similarly, the divergent responses to stimulation of the sym­
pathetic trunk can likewise be explained: erection induced by 
cavernous nerve stimulation or papaverine injection more 
closely mimics the normal physiologic event, and the resultant 
smooth-muscle relaxation is susceptible to suppression by sym­
pathetic stimulation; erection induced by saline perfusion can­
not be influenced because the cavernous smooth muscles have 
remained contracted. 
In human erectile dysfunction, venous leakage is diagnosed 
and quantified during cavernosometry by measuring the main­
tenance flow 4 > 5 · 8 1 2 and the intracavernous pressure drop after 
cessation of the saline perfusion.1314 The findings of Diederichs 
et al.7 and our results show that these parameters can be 
significantly influenced by sympathetic stimulation, which 
seems to increase the intracavernous adrenergic level that 
causes smooth muscle contraction.15 Carati and coworkers 
found that the cavernous smooth muscle contraction induced 
by sympathetic chain stimulation could be partially reduced by 
intracavernous injection of phentolamine.16 These findings sug­
gest that the intracavernous injection of papaverine and phen­
tolamine may reduce psychological inhibition during pharma-
cocavernosometry. Nevertheless, our clinical experience has 
shown that even when high doses of papaverine and phentol­
amine are injected intracavernously, full erectile response can 
still be inhibited by nervousness or anxiety of the patient. 
Thus, pharmacocavernosometry should be performed only in a 
relaxed setting after the physician has gained the patient's 
confidence. Any remaining nervousness or anxiety must be 
taken into account in the interpretation of the cavernosometric 
results. 
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